SCHEMBL17485392

SCHEMBL17485392

Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(ccn5C5CCNCC5)n4)ncc3F)cc2n1C(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.64
CDK6 Q00534 16/20 0.64
CDK2 P24941 14/20 0.64
CDK1 P06493 13/20 0.64
CDK9 P50750 8/20 0.64
CDK7 P50613 7/20 0.64
CCNB1 P14635 9/20 0.59
CCNE1 P24864 9/20 0.59
CDK5 Q00535 3/20 0.58
CCNT1 O60563 3/20 0.56
CCND3 P30281 3/20 0.56
EGFR P00533 2/20 0.55
NTRK1 P04629 2/20 0.55
BRAF P15056 2/20 0.55
CCNA2 P20248 2/20 0.55
KDR P35968 2/20 0.55
MAPK8 P45983 2/20 0.55
CCNH P51946 2/20 0.55
MNAT1 P51948 2/20 0.55
MAPK10 P53779 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17485391 0.95 CDK4 (0.62) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485388 0.92 CDK4 (0.64) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485301 0.91 CDK4 (0.71) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485336 0.89 CDK4 (0.71) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485349 0.89 CDK4 (0.61) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485390 0.86 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485351 0.85 CDK4 (0.62) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485341 0.84 CDK4 (0.59) CDK4CDK6CDK2CDK1CDK9
SCHEMBL17485347 0.84 CDK4 (0.59) CDK4CDK6CDK2CDK1CDK9
SCHEMBL3447322 0.84 CDK4 (0.67) CDK4CDK6CDK2CDK1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015604-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed